NEK4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.502600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.310600E-01
Normal-vs-Stage2
8.087400E-01
Normal-vs-Stage3
1.616090E-03
Normal-vs-Stage4
4.144800E-01
Stage1-vs-Stage2
5.071400E-01
Stage1-vs-Stage3
1.496090E-02
Stage1-vs-Stage4
4.227800E-01
Stage2-vs-Stage3
1.50886999999988E-05
Stage2-vs-Stage4
7.256100E-02
Stage3-vs-Stage4
5.975800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.537000E-01
Normal-vs-AfricanAmerican
8.489400E-01
Normal-vs-Asian
6.439800E-01
Caucasian-vs-AfricanAmerican
6.125800E-01
Caucasian-vs-Asian
5.826200E-01
AfricanAmerican-vs-Asian
4.331400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.489800E-01
Normal-vs-Female
8.605600E-01
Male-vs-Female
9.502200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.681600E-01
Normal-vs-Age(41-60Yrs)
8.164400E-01
Normal-vs-Age(61-80Yrs)
7.359200E-01
Normal-vs-Age(81-100Yrs)
3.403400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.382600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.184000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.044600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.599800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.915900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.914600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.598800E-01
Normal-vs-Daily Drinker
3.440600E-01
Normal-vs-Weekly Drinker
6.384400E-01
Normal-vs-Occasional Drinker
7.674200E-01
Normal-vs-Social Drinker
9.784600E-01
Non Drinker-vs-Daily Drinker
3.440000E-01
Non Drinker-vs-Weekly Drinker
9.315400E-01
Non Drinker-vs-Occasional Drinker
9.771700E-02
Non Drinker-vs-Social Drinker
3.804400E-01
Daily Drinker-vs-Weekly Drinker
4.151400E-01
Daily Drinker-vs-Occasional Drinker
3.493600E-02
Daily Drinker-vs-Social Drinker
1.504200E-01
Weekly Drinker-vs-Occasional Drinker
2.298000E-01
Weekly Drinker-vs-Social Drinker
5.371000E-01
Occasional Drinker-vs-Social Drinker
5.755200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.269000E-01
Normal-vs-Grade 2
4.679700E-02
Normal-vs-Grade 3
6.098100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.716600E-01
Grade 1-vs-Grade 3
5.097200E-01
Grade 1-vs-Grade 4
2.269000E-01
Grade 2-vs-Grade 3
4.118800E-01
Grade 2-vs-Grade 4
4.679700E-02
Grade 3-vs-Grade 4
6.098100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.964600E-01
Normal-vs-NonDiabetic
8.011000E-01
Diabetic-vs-NonDiabetic
1.917820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.995000E-01
Normal-vs-NoPancreatitis
7.890000E-01
Pancreatitis-vs-NoPancreatitis
3.339200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.888200E-01
Normal-vs-N1
7.902200E-01
N0-vs-N1
5.395600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.619000E-01
Normal-vs-TP53-NonMutant
8.992800E-01
TP53-Mutant-vs-TP53-NonMutant
7.508400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
